CD274 and neoplasm: Therefore, inhibition of PD1-PD-L1 axis may generate a synergistic effect to boost anti-tumor immunity, simultaneously reinvigorating metabolic fitness of TILs and inhibiting aberrant metabolic profiles of tumor cells.